Japan· JP-1179019M2034
ヒドロキシジンパモ酸塩
A hydroxyzine product containing ヒドロキシジンパモ酸塩, registered in Japan by ファイザー, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Hydroxyzine is registered in 15 of 19 countries.
Countries holding a registration under ATC N05BB01 (hydroxyzine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 8 of them publish a price we can compare per daily dose
Hydroxyzine · ATC N05BB01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydroxyzine costs, country by country.
Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.16 in United States to $1.68 in Switzerland — a ×11 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Hydroxyzine · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.68
- US United States$0.16 (acquisition cost)
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ヒドロキシジンパモ酸塩
- Manufacturer
- ファイザー
- Country
- Japan (JP)
- ATC code
- N05BB01
- ATC class
- Hydroxyzine
- Defined daily dose
- 75 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
410 interactions on record for hydroxyzine.
Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxyzine · interactions on record
410 records
- 46 severe
- 199 moderate
- 5 minor
- 160 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hydroxyzine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesHydroxyzineHenry Schein, Inc.
- United KingdomAtarax 10mg tabletsAlliance Pharmaceuticals Ltd
- PolandAtaraxUCB Pharma S.A.
- SwedenAtarax 10 mg Filmdragerad tablettUCB Nordic A/S
- FranceATARAX 2 mg/mL, siropUCB PHARMA
- FinlandAtaraxParanova Oy
- NorwayAtaraxUCB Nordic A/S
- IcelandAtaraxUCB Nordic A/S
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Atarax, Hydroxyzin Bluefish
- Belgium · Atarax
- Bulgaria · Атаракс, Неуролакс
- Cyprus · Atarax
- Czechia · Atarax
- Germany · Atarax, Hydroxyzin Bluefish
- Denmark · Hydroxyzine Bluefish, Hydroxyzine Medical Valley
- Spain · Atarax, Hidroxizina Bluefish
- Finland · Atarax, Hydroxyzine Orifarm
- France · Atarax, Hydroxyzine Arrow
- United Kingdom (Northern Ireland) · Atarax, Hydroxyzine Hydrochloride 25mg
- Greece · Atarax, Efidac
- Hungary · Atarax
- Ireland · Hydroxyzine Hydrochloride Brillpharma (Ireland)
- Iceland · Atarax, Hydroxyzine Bluefish
- Italy · Atarax
- Luxembourg · Atarax
- Netherlands · Hydroxyzine-2hcl Ucb Pharma
- Norway · Atarax, Hydroxyzine Bluefish
- Poland · Atarax, Comfortin
- Portugal · Atarax, Fenartix
- Sweden · Atarax, Hydroxizin Omet Pharma
- Slovakia · Atarax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61d44af2-1c0c-4efd-9e67-bf7b0129bc1a GET /v1/drugs/61d44af2-1c0c-4efd-9e67-bf7b0129bc1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５０ｍｇ１カプセル",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1179019M2034",
"category": "内用薬",
"price_yen": 6.3,
"generic_name": "ヒドロキシジンパモ酸塩",
"product_name_jp": null,
"therapeutic_class": "1179",
"transitional_expiry": null
}See everything about hydroxyzine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.